NIH-funded research Fellowship grant

Understanding swallowing and airway function in sporadic inclusion body myositis

Official title: Profiling Upper Aerodigestive Functioning in Sporadic Inclusion Body Myositis

Funded at University of Pittsburgh at Pittsburgh · NIH-10997659 · Data updated 2026-11-12

This study is looking at how sporadic inclusion body myositis affects swallowing and breathing functions, especially since problems with swallowing can lead to serious issues like pneumonia, and it's for people with this condition to help understand their challenges better.

More Myositis research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 30, 2024
Project endSeptember 29, 2025
Funding year2024
Award (this year)$48,974
NIH project number1F31HL176098-01
Project IDNIH-10997659 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with sporadic inclusion body myositis who experience swallowing difficulties.

Less likely to help

Patients with other forms of myositis or those without swallowing impairments may not benefit from this research.

What this research studies

This research investigates how sporadic inclusion body myositis (IBM) affects upper aerodigestive functions, particularly swallowing and airway clearance. It aims to identify the mechanisms behind swallowing impairments, known as dysphagia, which significantly contribute to early mortality in IBM patients due to aspiration pneumonia. By utilizing the Modified Barium Swallow Impairment Profile (MBSImP), the study will analyze swallowing physiology in patients with IBM compared to healthy individuals. Additionally, it will explore airway clearance abilities, which are crucial for preventing aspiration-related complications.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnosis and management strategies for patients with sporadic inclusion body myositis, enhancing their quality of life and reducing mortality risk.

How similar studies have gone: Previous research has shown success in using similar methodologies to assess swallowing dysfunction in other neurological disorders, indicating potential for meaningful insights in this study.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Ambrocio, Kevin Renz — University of Pittsburgh at Pittsburgh
  • Study coordinator: Ambrocio, Kevin Renz

Related research

Other NIH-funded projects on the same topics.

  • Myositis-ILD Risk Prediction: How ILD Progresses in Myositis Patients

    A study to build better tools that predict how lung disease linked to myositis will behave in diverse patients.

    NIH research University of Pennsylvania · Philadelphia, United States · NIH-11416500

  • Autoantibodies and membrane repair in myositis

    A blood and tissue study seeks to understand how immune reactions against muscle repair proteins contribute to inflammatory myositis, with the goal of guiding better treatments for people with this condition.

    NIH research Ohio State University · Columbus, UNITED STATES · NIH-11381103

  • Why chikungunya causes long-lasting joint and muscle pain

    This work looks at how chikungunya virus can linger in joint and muscle cells and keep causing pain for people who had the infection.

    NIH research Washington University · Saint Louis, United States · NIH-11325369

  • Autoantibodies against muscle membrane repair proteins in myositis

    This work looks at whether people with myositis have antibodies that attack proteins that fix damaged muscle cell membranes and how that may cause muscle inflammation and weakness.

    NIH research Ohio State University · Columbus, UNITED STATES · NIH-11196770

  • Predicting lung disease outcomes in people with myositis

    This project combines medical information and genetic markers to predict which people with myositis will have worsening interstitial lung disease.

    NIH research University of Pennsylvania · Philadelphia, United States · NIH-11193816

  • Cancer risk in inflammatory muscle disease (myositis)

    This project looks for signs in people with idiopathic inflammatory myopathies that show whether they have or might develop cancer.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11174212

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.